Skip to content
6-K

Foreign Interim / Material

Bioceres Crop Solutions Corp. BIOX

0001104659-26-027761

← back to feed
Filed
Mar 13, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2026 · Dec 31, 2025 63.48M sh
Shares Diluted Q2 2026 · Dec 31, 2025 63.48M sh
Shares Diluted Q2 2026 · Dec 31, 2024 62.82M sh
Shares Diluted Q2 2026 · Dec 31, 2024 62.82M sh
Operating Cash Flow Q2 2026 · Dec 31, 2025 $31.77M
Operating Cash Flow Q2 2026 · Dec 31, 2024 −$200.36K
Cash And Equivalents Q2 2026 · Dec 31, 2025 $11.06M
Cash And Equivalents Q2 2026 · Jun 30, 2025 $32.7M
Stockholders Equity Q2 2026 · Dec 31, 2025 $106.62M
Stockholders Equity Q2 2026 · Jun 30, 2025 $295.22M
Stockholders Equity Q2 2026 · Dec 31, 2024 $346.33M
Stockholders Equity Q2 2026 · Jun 30, 2024 $351.38M
Current Liabilities Q2 2026 · Dec 31, 2025 $328.64M
Current Liabilities Q2 2026 · Jun 30, 2025 $337.99M
Total Liabilities Q2 2026 · Dec 31, 2025 $453.75M
Total Liabilities Q2 2026 · Jun 30, 2025 $468.43M
Current Assets Q2 2026 · Dec 31, 2025 $294.28M
Current Assets Q2 2026 · Jun 30, 2025 $308.31M
Total Assets Q2 2026 · Dec 31, 2025 $560.36M
Total Assets Q2 2026 · Jun 30, 2025 $763.65M
Eps Diluted Q2 2026 · Dec 31, 2025 −$2.88
Eps Diluted Q2 2026 · Dec 31, 2025 −$3.00
Eps Diluted Q2 2026 · Dec 31, 2024 $0.00
Eps Diluted Q2 2026 · Dec 31, 2024 −$0.10
Eps Basic Q2 2026 · Dec 31, 2025 −$2.88
Eps Basic Q2 2026 · Dec 31, 2025 −$3.00
Eps Basic Q2 2026 · Dec 31, 2024 $0.00
Eps Basic Q2 2026 · Dec 31, 2024 −$0.10
Sga Expense Q2 2026 · Dec 31, 2025 $17.14M
Sga Expense Q2 2026 · Dec 31, 2025 $34.33M
Sga Expense restated Q2 2026 · Dec 31, 2024 $25.35M
Sga Expense restated Q2 2026 · Dec 31, 2024 $48.96M
Rd Expense Q2 2026 · Dec 31, 2025 $2.35M
Rd Expense Q2 2026 · Dec 31, 2025 $6M
Rd Expense restated Q2 2026 · Dec 31, 2024 $1.97M
Rd Expense restated Q2 2026 · Dec 31, 2024 $4.36M
Net Income Q2 2026 · Dec 31, 2025 −$182.47M
Net Income Q2 2026 · Dec 31, 2025 −$189.92M
Net Income Q2 2026 · Dec 31, 2024 $605.24K
Net Income Q2 2026 · Dec 31, 2024 −$5.59M
Operating Income Q2 2026 · Dec 31, 2025 $7.52M
Operating Income Q2 2026 · Dec 31, 2025 $17.21M
Operating Income restated Q2 2026 · Dec 31, 2024 $14.36M
Operating Income restated Q2 2026 · Dec 31, 2024 $19.62M
Gross Profit Q2 2026 · Dec 31, 2025 $26.65M
Gross Profit Q2 2026 · Dec 31, 2025 $57.42M
Gross Profit restated Q2 2026 · Dec 31, 2024 $41.54M
Gross Profit restated Q2 2026 · Dec 31, 2024 $73.34M
Cost Of Revenue Q2 2026 · Dec 31, 2025 $47.15M
Cost Of Revenue Q2 2026 · Dec 31, 2025 $85.52M
Cost Of Revenue restated Q2 2026 · Dec 31, 2024 $57.26M
Cost Of Revenue restated Q2 2026 · Dec 31, 2024 $109.56M
Revenue Q2 2026 · Dec 31, 2025 $73.81M
Revenue Q2 2026 · Dec 31, 2025 $142.93M
Revenue restated Q2 2026 · Dec 31, 2024 $98.8M
Revenue restated Q2 2026 · Dec 31, 2024 $182.9M
Dividends Paid Q2 2026 · Dec 31, 2024 $72.05K